 |
D.C. Municipal Regulations (Last Updated: September 13, 2017) |
 |
Title 22. HEALTH |
|
SubTilte 22-B. PUBLIC HEALTH AND MEDICINE |
|
Chapter 22-B2. COMMUNICABLE AND REPORTABLE DISEASES |
Section 22-B207. HEPATITIS B TESTING AND VACCINATION
-
207.1A provider that attends to, treats, or examines a pregnant woman or provides perinatal treatment shall:
(a)Take a blood sample during the first prenatal visit and submit the sample to a laboratory approved by the Department for testing for Hepatitis B Surface Antigen (HBsAg);
(b)Take a blood sample at the time of delivery if the woman has not had prior perinatal services or no documentation of HBsAg status, and submit the sample to a laboratory approved by the Department for testing HBsAg;
(c)Maintain a record of the woman's Hepatitis B status in her patient file; and
(d)Make a report according to the requirements of Subsection 201.5.
207.2A provider that delivers a newborn shall:
(a)Document the mother's Hepatitis B status in the newborn's records;
(b)Immunize the newborn for the Hepatitis B virus; and
(c)Make a report according to the requirements of Subsection 207.7.
207.3A newborn whose mother tests positive for HBsAg shall:
(a)Receive Hepatitis B immunoglobulin (HBIG) and Hepatitis B vaccine within twelve (12) hours of birth according to the recommendations of the Advisory Committee on Immunization Practices (ACIP);
(b)Receive a complete Hepatitis B series according to the schedule found at 22-B DCMR § 135; and
(c)Receive post-vaccination testing for the presence of HBsAg and Hepatitis B Surface Antibody (HBsAb) three (3) months after the last dose of Hepatitis B vaccine but not earlier than nine (9) months of age and no later than nineteen (19) months of age.
207.4A newborn whose mother's HBsAg status is unknown shall:
(a)Receive Hepatitis B vaccine without HBIG within twelve (12) hours of birth;
(b)Receive HBIG as soon as possible but no later than seven (7) days after birth if the newborn's mother tests positive for HBsAg;
(c)Receive a complete Hepatitis B series according to the schedule found at 22-B DCMR § 135; and
(d)Receive post-vaccination testing for the presence of HBsAg and Hepatitis B Surface Antibody (HBsAb) three (3) months after the last dose of Hepatitis B vaccine but not earlier than nine (9) months of age and no later than nineteen (19) months of age.
207.5A full-term medically stable newborn weighing two thousand grams (2000g) or more born to a mother who is HBsAg-negative shall:
(a)Receive Hepatitis B vaccine before hospital discharge; and
(b)Receive a complete Hepatitis B series according to the schedule found at 22-B DCMR § 135.
207.6A pre-term newborn weighing less than two thousand grams (2000g) born to a mother who is HBsAg-negative shall:
(a)Receive the first dose of Hepatitis B vaccine one (1) month after birth or at hospital discharge; and
(b)Receive a complete Hepatitis B series according to the schedule found at 22-B DCMR § 135.
207.7In addition to the reporting requirements of Subsection 201.5, a provider shall also report the following in the manner and form the Director requires:
(a)The date and time that Hepatitis B vaccine was administered;
(c)The date and time that Hepatitis B immunoglobulin was administered;
(d)The manufacturer of the vaccine; and
(e)The vaccine lot number.
207.8A newborn's parent or legal guardian shall be deemed to have consented to Hepatitis B vaccination, unless the newborn's parent or legal guardian submits a signed request for exemption that states the reasons for the exemption. A newborn may be exempted from vaccination if:
(a)The newborn's mother tested negative for HBsAg;
(b)The newborn's parent or legal guardian objects in good faith and in writing that immunization would violate his or her religious beliefs; or
(c)The newborn's parent or legal guardian provides the written certification of a physician that immunization is medically inadvisable.
207.9Information disclosed to the Department pursuant to this section shall be kept confidential and shall not be disclosed to a third party, except as provided in this subsection. The Department may use and disclose information received pursuant to this section as follows:
(a)The Director may use patient-specific immunization information:
(1)To produce aggregate immunization coverage reports and to track Hepatitis B levels;
(2)To ensure that newborns receive Hepatitis B immunization;
(3)To conduct follow-up on infants born to HBsAg positive mothers; and
(4)For statistical and public health purposes.
(b)Except as provided in subsection (a), the Director may disclose a person's individually identifiable information to a third party only with written consent of the person, or the person's parent or guardian if the person is under eighteen (18) years of age or an unemancipated adult.